According to the research report published by Market IntelliX, the global market for Implantable Drug Infusion Devices should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Implantable Drug Infusion Devices market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Implantable Drug Infusion Devices market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Hospital grew percent to account for percent of the total market sales, and Clinic grew percent.
Implantable drug infusion devices usually consist of drug infusion pumps, reperfusion components, and catheter inlet components. This product is used in conjunction with intrathecal catheters for long-term drug input
This report studies and analyses global Implantable Drug Infusion Devices status and future trends, helps the client to determine the Implantable Drug Infusion Devices market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Implantable Drug Infusion Devices, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Implantable Drug Infusion Devices market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Implantable Drug Infusion Devices sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Implantable Drug Infusion Devices sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Implantable Drug Infusion Devices key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Implantable Drug Infusion Devices key producing regions, capacity, production, and year over year growth
(6) Implantable Drug Infusion Devices industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Medtronic
Abbott
Linhua Medical
Districlass
PFM Medical
PakuMed
Medtronic
BD
AngioDynamics
Smiths Medical
Teleflex
Vygon
Cemma Medical
Abbott Laboratories
Market segment by Type, covers
Single Chamber
Double Chamber
Market segment by Application, can be divided into
Hospital
Clinic
Other
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Implantable Drug Infusion Devices product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Implantable Drug Infusion Devices market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Implantable Drug Infusion Devices market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Implantable Drug Infusion Devices, percent & CAGR, 2018-2029
Chapter 5: Implantable Drug Infusion Devices industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Implantable Drug Infusion Devices Definition
1.2 Global Implantable Drug Infusion Devices Market Size and Forecast
1.2.1 By Consumption Value, Global Implantable Drug Infusion Devices Market Size,2018-2029
1.2.2 By Sales Quantity, Global Implantable Drug Infusion Devices Market Size,2018-2029
1.2.3 Global Implantable Drug Infusion Devices Average Selling Price (ASP),2018-2029
1.3 China Implantable Drug Infusion Devices Market Size and Forecast
1.3.1 By Consumption Value, China Implantable Drug Infusion Devices Market Size,2018-2029
1.3.2 By Sales Quantity, China Implantable Drug Infusion Devices Market Size,2018-2029
1.3.3 China Implantable Drug Infusion Devices Average Selling Price (ASP), 2018-2029
1.4 Share of China Implantable Drug Infusion Devices Market with Respect to the Global Market
1.4.1 By Consumption Value, China Implantable Drug Infusion Devices Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Implantable Drug Infusion Devices Market Share in Global, 2018-2029
1.4.3 Implantable Drug Infusion Devices Market Size: China VS Global, 2018-2029
1.5 Implantable Drug Infusion Devices Market Dynamics
1.5.1 Implantable Drug Infusion Devices Market Drivers
1.5.2 Implantable Drug Infusion Devices Market Restraints
1.5.3 Implantable Drug Infusion Devices Industry Trends
1.5.4 Implantable Drug Infusion Devices Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Implantable Drug Infusion Devices, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Implantable Drug Infusion Devices, Global Market Share by Company, 2018-2023
2.3 Implantable Drug Infusion Devices Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Implantable Drug Infusion Devices Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Implantable Drug Infusion Devices Concentration Ratio
2.6 Global Implantable Drug Infusion Devices Mergers & Acquisitions, Expansion Plans
2.7 Global Implantable Drug Infusion Devices Manufacturers Product Type
2.8 Head Office and Implantable Drug Infusion Devices Production Site of Key Manufacturer
2.9 Implantable Drug Infusion Devices Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Implantable Drug Infusion Devices, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Implantable Drug Infusion Devices, China Market Share by Company, 2018-2023
3.3 China Implantable Drug Infusion Devices Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Implantable Drug Infusion Devices Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Implantable Drug Infusion Devices Capacity by Region
4.3 Global Implantable Drug Infusion Devices Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Implantable Drug Infusion Devices Production by Region, 2018-2029
4.5 Global Implantable Drug Infusion Devices Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Implantable Drug Infusion Devices Industry Chain
5.2 Implantable Drug Infusion Devices Upstream Analysis
5.2.1 Implantable Drug Infusion Devices Core Raw Materials
5.2.2 Main Manufacturers of Implantable Drug Infusion Devices Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Implantable Drug Infusion Devices Production Mode
5.6 Implantable Drug Infusion Devices Procurement Model
5.7 Implantable Drug Infusion Devices Industry Sales Model and Sales Channels
5.7.1 Implantable Drug Infusion Devices Sales Model
5.7.2 Implantable Drug Infusion Devices Typical Distributors
6 Sights by Type
6.1 Implantable Drug Infusion Devices Classification
6.1.1 Single Chamber
6.1.2 Double Chamber
6.2 By Type, Global Implantable Drug Infusion Devices Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Implantable Drug Infusion Devices Consumption Value, 2018-2029
6.4 By Type, Global Implantable Drug Infusion Devices Sales Quantity, 2018-2029
6.5 By Type, Global Implantable Drug Infusion Devices Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Implantable Drug Infusion Devices Segment by Application
7.1.1 Hospital
7.1.2 Clinic
7.1.3 Other
7.2 By Application, Global Implantable Drug Infusion Devices Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Implantable Drug Infusion Devices Consumption Value, 2018-2029
7.4 By Application, Global Implantable Drug Infusion Devices Sales Quantity, 2018-2029
7.5 By Application, Global Implantable Drug Infusion Devices Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Implantable Drug Infusion Devices Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Implantable Drug Infusion Devices Consumption Value, 2018-2029
8.3 By Region, Global Implantable Drug Infusion Devices Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Implantable Drug Infusion Devices & Forecasts, 2018-2029
8.4.2 By Country, North America Implantable Drug Infusion Devices Market Size Market Share
8.5 Europe
8.5.1 Europe Implantable Drug Infusion Devices Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Implantable Drug Infusion Devices Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Implantable Drug Infusion Devices Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Implantable Drug Infusion Devices Market Size Market Share
8.7 South America
8.7.1 South America Implantable Drug Infusion Devices Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Implantable Drug Infusion Devices Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Implantable Drug Infusion Devices Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Implantable Drug Infusion Devices Consumption Value, 2018-2029
9.3 By Country, Global Implantable Drug Infusion Devices Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Implantable Drug Infusion Devices Market Size, 2018-2029
9.4.2 By Type, U.S. Implantable Drug Infusion Devices Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Implantable Drug Infusion Devices Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Implantable Drug Infusion Devices Market Size, 2018-2029
9.5.2 By Type, Europe Implantable Drug Infusion Devices Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Implantable Drug Infusion Devices Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Implantable Drug Infusion Devices Market Size, 2018-2029
9.6.2 By Type, China Implantable Drug Infusion Devices Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Implantable Drug Infusion Devices Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Implantable Drug Infusion Devices Market Size, 2018-2029
9.7.2 By Type, Japan Implantable Drug Infusion Devices Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Implantable Drug Infusion Devices Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Implantable Drug Infusion Devices Market Size, 2018-2029
9.8.2 By Type, South Korea Implantable Drug Infusion Devices Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Implantable Drug Infusion Devices Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Implantable Drug Infusion Devices Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Implantable Drug Infusion Devices Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Implantable Drug Infusion Devices Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Implantable Drug Infusion Devices Market Size, 2018-2029
9.10.2 By Type, India Implantable Drug Infusion Devices Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Implantable Drug Infusion Devices Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Implantable Drug Infusion Devices Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Implantable Drug Infusion Devices Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Implantable Drug Infusion Devices Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Medtronic
10.1.1 Medtronic Company Information, Head Office, Market Area, and Industry Position
10.1.2 Medtronic Implantable Drug Infusion Devices Models, Specifications, and Application
10.1.3 Medtronic Implantable Drug Infusion Devices Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Medtronic Company Profile and Main Business
10.1.5 Medtronic Recent Developments
10.2 Abbott
10.2.1 Abbott Company Information, Head Office, Market Area, and Industry Position
10.2.2 Abbott Implantable Drug Infusion Devices Models, Specifications, and Application
10.2.3 Abbott Implantable Drug Infusion Devices Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Abbott Company Profile and Main Business
10.2.5 Abbott Recent Developments
10.3 Linhua Medical
10.3.1 Linhua Medical Company Information, Head Office, Market Area, and Industry Position
10.3.2 Linhua Medical Implantable Drug Infusion Devices Models, Specifications, and Application
10.3.3 Linhua Medical Implantable Drug Infusion Devices Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Linhua Medical Company Profile and Main Business
10.3.5 Linhua Medical Recent Developments
10.4 Districlass
10.4.1 Districlass Company Information, Head Office, Market Area, and Industry Position
10.4.2 Districlass Implantable Drug Infusion Devices Models, Specifications, and Application
10.4.3 Districlass Implantable Drug Infusion Devices Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Districlass Company Profile and Main Business
10.4.5 Districlass Recent Developments
10.5 PFM Medical
10.5.1 PFM Medical Company Information, Head Office, Market Area, and Industry Position
10.5.2 PFM Medical Implantable Drug Infusion Devices Models, Specifications, and Application
10.5.3 PFM Medical Implantable Drug Infusion Devices Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 PFM Medical Company Profile and Main Business
10.5.5 PFM Medical Recent Developments
10.6 PakuMed
10.6.1 PakuMed Company Information, Head Office, Market Area, and Industry Position
10.6.2 PakuMed Implantable Drug Infusion Devices Models, Specifications, and Application
10.6.3 PakuMed Implantable Drug Infusion Devices Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 PakuMed Company Profile and Main Business
10.6.5 PakuMed Recent Developments
10.7 Medtronic
10.7.1 Medtronic Company Information, Head Office, Market Area, and Industry Position
10.7.2 Medtronic Implantable Drug Infusion Devices Models, Specifications, and Application
10.7.3 Medtronic Implantable Drug Infusion Devices Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Medtronic Company Profile and Main Business
10.7.5 Medtronic Recent Developments
10.8 BD
10.8.1 BD Company Information, Head Office, Market Area, and Industry Position
10.8.2 BD Implantable Drug Infusion Devices Models, Specifications, and Application
10.8.3 BD Implantable Drug Infusion Devices Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 BD Company Profile and Main Business
10.8.5 BD Recent Developments
10.9 AngioDynamics
10.9.1 AngioDynamics Company Information, Head Office, Market Area, and Industry Position
10.9.2 AngioDynamics Implantable Drug Infusion Devices Models, Specifications, and Application
10.9.3 AngioDynamics Implantable Drug Infusion Devices Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 AngioDynamics Company Profile and Main Business
10.9.5 AngioDynamics Recent Developments
10.10 Smiths Medical
10.10.1 Smiths Medical Company Information, Head Office, Market Area, and Industry Position
10.10.2 Smiths Medical Implantable Drug Infusion Devices Models, Specifications, and Application
10.10.3 Smiths Medical Implantable Drug Infusion Devices Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Smiths Medical Company Profile and Main Business
10.10.5 Smiths Medical Recent Developments
10.11 Teleflex
10.11.1 Teleflex Company Information, Head Office, Market Area, and Industry Position
10.11.2 Teleflex Implantable Drug Infusion Devices Models, Specifications, and Application
10.11.3 Teleflex Implantable Drug Infusion Devices Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Teleflex Company Profile and Main Business
10.11.5 Teleflex Recent Developments
10.12 Vygon
10.12.1 Vygon Company Information, Head Office, Market Area, and Industry Position
10.12.2 Vygon Implantable Drug Infusion Devices Models, Specifications, and Application
10.12.3 Vygon Implantable Drug Infusion Devices Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Vygon Company Profile and Main Business
10.12.5 Vygon Recent Developments
10.13 Cemma Medical
10.13.1 Cemma Medical Company Information, Head Office, Market Area, and Industry Position
10.13.2 Cemma Medical Implantable Drug Infusion Devices Models, Specifications, and Application
10.13.3 Cemma Medical Implantable Drug Infusion Devices Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Cemma Medical Company Profile and Main Business
10.13.5 Cemma Medical Recent Developments
10.14 Abbott Laboratories
10.14.1 Abbott Laboratories Company Information, Head Office, Market Area, and Industry Position
10.14.2 Abbott Laboratories Implantable Drug Infusion Devices Models, Specifications, and Application
10.14.3 Abbott Laboratories Implantable Drug Infusion Devices Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Abbott Laboratories Company Profile and Main Business
10.14.5 Abbott Laboratories Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Implantable Drug Infusion Devices Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Implantable Drug Infusion Devices Market Restraints
Table 3. Implantable Drug Infusion Devices Market Trends
Table 4. Implantable Drug Infusion Devices Industry Policy
Table 5. Global Implantable Drug Infusion Devices Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Implantable Drug Infusion Devices Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Implantable Drug Infusion Devices Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Implantable Drug Infusion Devices Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Implantable Drug Infusion Devices Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Implantable Drug Infusion Devices Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Implantable Drug Infusion Devices Mergers & Acquisitions, Expansion Plans
Table 12. Global Implantable Drug Infusion Devices Manufacturers Product Type
Table 13. Head Office and Implantable Drug Infusion Devices Production Site of Key Manufacturer
Table 14. Implantable Drug Infusion Devices Capacity of Major Manufacturers and Future Plan
Table 15. China Implantable Drug Infusion Devices Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Implantable Drug Infusion Devices Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Implantable Drug Infusion Devices Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Implantable Drug Infusion Devices Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Implantable Drug Infusion Devices Production by Region, 2018-2023, (K Units)
Table 20. Global Implantable Drug Infusion Devices Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Implantable Drug Infusion Devices Upstream (Raw Materials)
Table 22. Global Implantable Drug Infusion Devices Typical Customers
Table 23. Implantable Drug Infusion Devices Typical Distributors
Table 24. By Type, Global Implantable Drug Infusion Devices Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Implantable Drug Infusion Devices Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Implantable Drug Infusion Devices Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Implantable Drug Infusion Devices Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Implantable Drug Infusion Devices Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Implantable Drug Infusion Devices Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Implantable Drug Infusion Devices Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Implantable Drug Infusion Devices Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Implantable Drug Infusion Devices Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Implantable Drug Infusion Devices Sales Quantity Market Share, 2018-2029
Table 34. Medtronic Company Information, Head Office, Market Area, and Industry Position
Table 35. Medtronic Implantable Drug Infusion Devices Models, Specifications, and Application
Table 36. Medtronic Implantable Drug Infusion Devices Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Medtronic Company Profile and Main Business
Table 38. Medtronic Recent Developments
Table 39. Abbott Company Information, Head Office, Market Area, and Industry Position
Table 40. Abbott Implantable Drug Infusion Devices Models, Specifications, and Application
Table 41. Abbott Implantable Drug Infusion Devices Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Abbott Company Profile and Main Business
Table 43. Abbott Recent Developments
Table 44. Linhua Medical Company Information, Head Office, Market Area, and Industry Position
Table 45. Linhua Medical Implantable Drug Infusion Devices Models, Specifications, and Application
Table 46. Linhua Medical Implantable Drug Infusion Devices Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Linhua Medical Company Profile and Main Business
Table 48. Linhua Medical Recent Developments
Table 49. Districlass Company Information, Head Office, Market Area, and Industry Position
Table 50. Districlass Implantable Drug Infusion Devices Models, Specifications, and Application
Table 51. Districlass Implantable Drug Infusion Devices Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Districlass Company Profile and Main Business
Table 53. Districlass Recent Developments
Table 54. PFM Medical Company Information, Head Office, Market Area, and Industry Position
Table 55. PFM Medical Implantable Drug Infusion Devices Models, Specifications, and Application
Table 56. PFM Medical Implantable Drug Infusion Devices Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. PFM Medical Company Profile and Main Business
Table 58. PFM Medical Recent Developments
Table 59. PakuMed Company Information, Head Office, Market Area, and Industry Position
Table 60. PakuMed Implantable Drug Infusion Devices Models, Specifications, and Application
Table 61. PakuMed Implantable Drug Infusion Devices Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. PakuMed Company Profile and Main Business
Table 63. PakuMed Recent Developments
Table 64. Medtronic Company Information, Head Office, Market Area, and Industry Position
Table 65. Medtronic Implantable Drug Infusion Devices Models, Specifications, and Application
Table 66. Medtronic Implantable Drug Infusion Devices Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Medtronic Company Profile and Main Business
Table 68. Medtronic Recent Developments
Table 69. BD Company Information, Head Office, Market Area, and Industry Position
Table 70. BD Implantable Drug Infusion Devices Models, Specifications, and Application
Table 71. BD Implantable Drug Infusion Devices Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. BD Company Profile and Main Business
Table 73. BD Recent Developments
Table 74. AngioDynamics Company Information, Head Office, Market Area, and Industry Position
Table 75. AngioDynamics Implantable Drug Infusion Devices Models, Specifications, and Application
Table 76. AngioDynamics Implantable Drug Infusion Devices Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. AngioDynamics Company Profile and Main Business
Table 78. AngioDynamics Recent Developments
Table 79. Smiths Medical Company Information, Head Office, Market Area, and Industry Position
Table 80. Smiths Medical Implantable Drug Infusion Devices Models, Specifications, and Application
Table 81. Smiths Medical Implantable Drug Infusion Devices Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Smiths Medical Company Profile and Main Business
Table 83. Smiths Medical Recent Developments
Table 84. Teleflex Company Information, Head Office, Market Area, and Industry Position
Table 85. Teleflex Implantable Drug Infusion Devices Models, Specifications, and Application
Table 86. Teleflex Implantable Drug Infusion Devices Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Teleflex Company Profile and Main Business
Table 88. Teleflex Recent Developments
Table 89. Vygon Company Information, Head Office, Market Area, and Industry Position
Table 90. Vygon Implantable Drug Infusion Devices Models, Specifications, and Application
Table 91. Vygon Implantable Drug Infusion Devices Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Vygon Company Profile and Main Business
Table 93. Vygon Recent Developments
Table 94. Cemma Medical Company Information, Head Office, Market Area, and Industry Position
Table 95. Cemma Medical Implantable Drug Infusion Devices Models, Specifications, and Application
Table 96. Cemma Medical Implantable Drug Infusion Devices Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Cemma Medical Company Profile and Main Business
Table 98. Cemma Medical Recent Developments
Table 99. Abbott Laboratories Company Information, Head Office, Market Area, and Industry Position
Table 100. Abbott Laboratories Implantable Drug Infusion Devices Models, Specifications, and Application
Table 101. Abbott Laboratories Implantable Drug Infusion Devices Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Abbott Laboratories Company Profile and Main Business
Table 103. Abbott Laboratories Recent Developments
List of Figures
Figure 1. Implantable Drug Infusion Devices Picture
Figure 2. Global Implantable Drug Infusion Devices Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Implantable Drug Infusion Devices Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Implantable Drug Infusion Devices Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Implantable Drug Infusion Devices Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Implantable Drug Infusion Devices Sales Quantity (K Units) & (2018-2029)
Figure 7. China Implantable Drug Infusion Devices Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Implantable Drug Infusion Devices Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Implantable Drug Infusion Devices Market Share of Global, 2018-2029
Figure 10. Global Implantable Drug Infusion Devices Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Implantable Drug Infusion Devices Key Participants, Market Share, 2022
Figure 12. Global Implantable Drug Infusion Devices Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Implantable Drug Infusion Devices Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Implantable Drug Infusion Devices Production Market Share & Forecast by Region, 2018-2029
Figure 15. Implantable Drug Infusion Devices Industry Chain
Figure 16. Implantable Drug Infusion Devices Procurement Model
Figure 17. Implantable Drug Infusion Devices Sales Model
Figure 18. Implantable Drug Infusion Devices Sales Channels, Direct Sales, and Distribution
Figure 19. Single Chamber
Figure 20. Double Chamber
Figure 21. By Type, Global Implantable Drug Infusion Devices Consumption Value, 2018-2029, US$ Million
Figure 22. By Type, Global Implantable Drug Infusion Devices Consumption Value Market Share, 2018-2029
Figure 23. By Type, Global Implantable Drug Infusion Devices Sales Quantity, 2018-2029, (K Units)
Figure 24. By Type, Global Implantable Drug Infusion Devices Sales Quantity Market Share, 2018-2029
Figure 25. By Type, Global Implantable Drug Infusion Devices Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 26. Hospital
Figure 27. Clinic
Figure 28. Other
Figure 29. By Application, Global Implantable Drug Infusion Devices Consumption Value, 2018-2029, US$ Million
Figure 30. By Application, Global Implantable Drug Infusion Devices Consumption Value Market Share, 2018-2029
Figure 31. By Application, Global Implantable Drug Infusion Devices Sales Quantity, 2018-2029, (K Units)
Figure 32. By Application, Global Implantable Drug Infusion Devices Sales Quantity Market Share, 2018-2029
Figure 33. By Application, Global Implantable Drug Infusion Devices Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 34. By Region, Global Implantable Drug Infusion Devices Consumption Value Market Share, 2018-2029
Figure 35. By Region, Global Implantable Drug Infusion Devices Sales Quantity Market Share, 2018-2029
Figure 36. North America Implantable Drug Infusion Devices Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 37. By Country, North America Implantable Drug Infusion Devices Consumption Value Market Share, 2022
Figure 38. Europe Implantable Drug Infusion Devices Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 39. By Country, Europe Implantable Drug Infusion Devices Consumption Value Market Share, 2022
Figure 40. Asia Pacific Implantable Drug Infusion Devices Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 41. By Country/Region, Asia Pacific Implantable Drug Infusion Devices Consumption Value Market Share, 2022
Figure 42. South America Implantable Drug Infusion Devices Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, South America Implantable Drug Infusion Devices Consumption Value Market Share, 2022
Figure 44. Middle East & Africa Implantable Drug Infusion Devices Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. U.S. Implantable Drug Infusion Devices Sales Quantity, 2018-2029, (K Units)
Figure 46. By Type, U.S. Implantable Drug Infusion Devices Sales Quantity Market Share, 2022 VS 2029
Figure 47. By Application, U.S. Implantable Drug Infusion Devices Sales Quantity Market Share, 2022 VS 2029
Figure 48. Europe Implantable Drug Infusion Devices Sales Quantity, 2018-2029, (K Units)
Figure 49. By Type, Europe Implantable Drug Infusion Devices Sales Quantity Market Share, 2022 VS 2029
Figure 50. By Application, Europe Implantable Drug Infusion Devices Sales Quantity Market Share, 2022 VS 2029
Figure 51. China Implantable Drug Infusion Devices Sales Quantity, 2018-2029, (K Units)
Figure 52. By Type, China Implantable Drug Infusion Devices Sales Quantity Market Share, 2022 VS 2029
Figure 53. By Application, China Implantable Drug Infusion Devices Sales Quantity Market Share, 2022 VS 2029
Figure 54. Japan Implantable Drug Infusion Devices Sales Quantity, 2018-2029, (K Units)
Figure 55. By Type, Japan Implantable Drug Infusion Devices Sales Quantity Market Share, 2022 VS 2029
Figure 56. By Application, Japan Implantable Drug Infusion Devices Sales Quantity Market Share, 2022 VS 2029
Figure 57. South Korea Implantable Drug Infusion Devices Sales Quantity, 2018-2029, (K Units)
Figure 58. By Type, South Korea Implantable Drug Infusion Devices Sales Quantity Market Share, 2022 VS 2029
Figure 59. By Application, South Korea Implantable Drug Infusion Devices Sales Quantity Market Share, 2022 VS 2029
Figure 60. Southeast Asia Implantable Drug Infusion Devices Sales Quantity, 2018-2029, (K Units)
Figure 61. By Type, Southeast Asia Implantable Drug Infusion Devices Sales Quantity Market Share, 2022 VS 2029
Figure 62. By Application, Southeast Asia Implantable Drug Infusion Devices Sales Quantity Market Share, 2022 VS 2029
Figure 63. India Implantable Drug Infusion Devices Sales Quantity, 2018-2029, (K Units)
Figure 64. By Type, India Implantable Drug Infusion Devices Sales Quantity Market Share, 2022 VS 2029
Figure 65. By Application, India Implantable Drug Infusion Devices Sales Quantity Market Share, 2022 VS 2029
Figure 66. Middle East & Africa Implantable Drug Infusion Devices Sales Quantity, 2018-2029, (K Units)
Figure 67. By Type, Middle East & Africa Implantable Drug Infusion Devices Sales Quantity Market Share, 2022 VS 2029
Figure 68. By Application, Middle East & Africa Implantable Drug Infusion Devices Sales Quantity Market Share, 2022 VS 2029
Figure 69. Research Methodology
Figure 70. Breakdown of Primary Interviews
Figure 71. Bottom-up and Top-down Approaches
Figure 72. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|